Ginkgo Bioworks reports Q4 revenue $33M, consensus $37.57M

Reports Q4 GAAP net loss of (81M) compared to (108M) in the comparable prior year period . “This year, we are going to focus on investing to win in the category of autonomous labs,” said Jason Kelly, co-founder and CEO of Ginkgo Bioworks (DNA). “There is an emerging wave of interest in robotics and AI, and our work with the Department of Energy and OpenAI this year shows that Ginkgo is in the best position to bring robotics to an extraordinarily high value area: laboratory research.”